CLOs on the Move

Titan Spine

www.titanspine.com

 
Titan Spine is a surface technology company that produces the only FDA-cleared nanotechnology interbody fusion devices that participate in the spinal fusion process.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Bigfoot Biomedical

Bigfoot Biomedical is a new kind of medical device company developing technologies to significantly reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes.

JenaValve

JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.

Bioanalytical Instruments

Bioanalytical Instruments is a Carolina, PR-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Immedica

Immedica is a Chatham, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CosMedical Technologies

For 25 years, we have set the standard for medical grade private label skincare. We have perfected the effectiveness of skincare products and have created an ideal private label experience. Designed for simplicity and efficiency, our branding process is one of the most streamlined and rewarding in the industry. We believe building loyalty to your own brand of quality skincare products is the key to taking your business to the next level and we are here to help you every step of the way.